Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Clinical Pharmacology and Therapeutics
|
February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms
Rhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
Julio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 22, 2019
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
Larisa H Cavallari, Sara L Van Driest, Cynthia A Prows, et al.
Clinical and Translational Science
|
September 25, 2021
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
Sony Tuteja, Ramzi G Salloum, Amanda L Elchynski, et al.
Implementation Science Communications
|
May 15, 2022
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
Ramzi G Salloum, Jeffrey R Bishop, Amanda L Elchynski, et al.
Clinical Pharmacology and Therapeutics
|
January 11, 2021
Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems
J Kevin Hicks, Nihal El Rouby, Henry H Ong, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Clinical Pharmacology and Therapeutics
|
February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms
Rhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
Julio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 22, 2019
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
Larisa H Cavallari, Sara L Van Driest, Cynthia A Prows, et al.
Clinical and Translational Science
|
September 25, 2021
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
Sony Tuteja, Ramzi G Salloum, Amanda L Elchynski, et al.
Implementation Science Communications
|
May 15, 2022
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
Ramzi G Salloum, Jeffrey R Bishop, Amanda L Elchynski, et al.
Clinical Pharmacology and Therapeutics
|
January 11, 2021
Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems
J Kevin Hicks, Nihal El Rouby, Henry H Ong, et al.
Page
of 9